| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962649 | Vaccine | 2016 | 7 Pages |
Abstract
Further research is needed on vaccine efficacy of the combination strategy and of risk groups, as well as the duration of vaccine protection. Serotype evolutions under the influence of the childhood PCV program should be closely monitored.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Adriaan Blommaert, Joke Bilcke, Lander Willem, Jan Verhaegen, Herman Goossens, Philippe Beutels,